BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the broad commercial launch of a SARS ...

Evaluation of a 'plaque reduction neutralization test'. Using blood samples from COVID-19 patients, this test detects the antibodies which neutralize the SARS-CoV-2 virus, i.e. stop the virus ...

Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern pose a challenge to the effectiveness of current vaccines. A vaccine that could prevent infection caused by ...

SARS-CoV-2 vaccine efficacy testing is now facing increasing challenges in the face of an ongoing pandemic with the emergence of new variants and waning vaccine immunity. Evidence supports the ...

St. Louis, MO – September, 28 2020 – Life Science Newswire – The COVID-19 pandemic is one of the most urgent infectious disease challenges the world has faced in recent history. Presently, few ...